InvestorsHub Logo
Followers 13
Posts 865
Boards Moderated 0
Alias Born 02/17/2017

Re: None

Tuesday, 08/01/2017 11:48:41 AM

Tuesday, August 01, 2017 11:48:41 AM

Post# of 879
Hi all,

Just starting research here, and the flow of information seems a bit limited. Two quick questions that would be very helpful if anyone were to have insight:

1) Has the company ever stated an end goal or exit strategy? Are they actually looking to take BIV201 to market, or are they trying to get to a sale/partner arrangement?

2) What in the world is going on with the trading volume? Average volume of less than 7k shares daily? I understand that it's a clinical stage, pre-revenue biotech... but it's also in P2 with a drug that has ODD. Seems odd.

Anything I should know off of the top of your collective heads?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIVI News